Marshall Wace
SPRY icon

Marshall Wace’s ARS Pharmaceuticals SPRY Stock Holding History

Marshall Wace’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$843K Buy
105,006
+25,792
+33% +$247K ﹤0.01% 2212
2025
Q4 		$923K Sell
79,214
-118,106
-60% -$1.15M ﹤0.01% 1975
2025
Q3 		$1.98M Buy
197,320
+157,406
+394% +$2.26M ﹤0.01% 1630
2025
Q2 		$697K Sell
39,914
-116,721
-75% -$1.68M ﹤0.01% 2012
2025
Q1 		$1.97M Buy
156,635
+103,729
+196% +$1.25M ﹤0.01% 1468
2024
Q4 		$558K Sell
52,906
-24,973
-32% -$350K ﹤0.01% 1993
2024
Q3 		$1.13M Buy
+77,879
New +$926K ﹤0.01% 1606
2023
Q3 		– Sell
-74,621
Closed -$500K – 2706
2023
Q2 		$500K Buy
74,621
+35,193
+89% +$235K ﹤0.01% 1987
2023
Q1 		$257K Buy
39,428
+7,417
+23% +$57K ﹤0.01% 2348
2022
Q4 		$273K Buy
+32,011
New +$208K ﹤0.01% 2595
2021
Q4 		– Sell
-275,567
Closed -$2.75M – 4337
2021
Q3 		$2.75M Buy
+275,567
New +$6.8M 0.01% 1322

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return